<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/989E7D51-B2C3-4470-999E-30C9AF5A5E4B"><gtr:id>989E7D51-B2C3-4470-999E-30C9AF5A5E4B</gtr:id><gtr:firstName>Bryan</gtr:firstName><gtr:surname>Charleston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001447"><gtr:id>55F8D804-69AF-4683-8E19-43CBA1DA7D7D</gtr:id><gtr:title>Understanding the maintenance of protective antibody titres in cattle</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001447</gtr:grantReference><gtr:abstractText>CD4 T cell assays have been developed and when combined with serological assays provide some correlation with protection and an association with prolonged duration of immunity. However, there are also examples where protection and maintenance of protective neutralising antibody titres post-vaccination is not associated with an easily detectable CD4 T cell response most notably after natural infection. We have recently demonstrated the long term retention of FMDV antigen in lymphoid tissue, this depot of antigen may play a key role in maintaining neutralising antibody titres after infection. The assays to measure CD4 T cell responses will be further refined to improve the specificity of the correlation with protection including using Multiparameter flow cytometry to measure intracellular cytokines and intracellular CD154. It is clear that apart from adjuvants, which operate by multiple mechanisms, persistence of antigen is an important factor in the maintenance of immune responses. The role of antigen present on follicular DCs will be investigated by using lymphotoxin &amp;szlig; receptor immunoglobulin fusion protein to disrupt FDC networks and associated antigen depots. Assays to quantify the memory B cell response will be adapted for use after FMDV infection and vaccination in cattle. The capacity to measure the frequency of plasma cells and memory B cells will significantly improve the ability to assess the potential of a vaccine to induce a long term serological response. In addition, using a mouse model of FMDV infection, improved assays will be developed to measure correlates of protection for FMDV in cattle. The importance of long-term retention of FMDV antigen, in germinal centres of lymphoid tissue after infection, in the maintenance of a high titre serological response will be studied. We aim to determine the influence of capsid stability on duration of protective immunity.</gtr:abstractText><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-07-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>1613682</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This programme has examined the responses of the natural host species (cattle and pigs) to viral infection, from the genome to the whole organism. Combining recent advances in our knowledge with cutting edge techniques and technologies enables a fundamental advance in our understanding of the host response. Using powerful comparative approaches we have dissected immune responses and functional differences, from initiation to the development of protection. By studying the
responses to vaccines, recombinant viruses and different viral serotypes alongside natural infection we will develop a
mechanistic understanding of the events that are required to induce protection and increase the duration of immunity. In
addition, understanding barriers to virus dissemination in vectors will not only allow us to understand and predict the
epidemiology of virus outbreaks, but also enable us to exploit emerging technologies to develop genetically modified
arthropods that are refractory to infection. Differential susceptibility can be influenced by the underlying genetic differences
of the host. The work in this programme will provide unique opportunities to characterise and study differences in the
genetics within and between host populations that influence the outcome of infection.</gtr:description><gtr:exploitationPathways>This programme of bioscience research has provided in-depth understanding of the immune systems of cattle and pigs. This knowledge contributes to interdisciplinary expertise in immunology, genetics, entomology, epigenetics, pathogenesis, vaccinology, mathematical biology and bioinformatics to examine fundamental properties of the host response to viral infection and translation of this knowledge into disease control measures. This research will be driven by answering the question &amp;quot;What properties of the host response to virus infections determine if disease occurs and if viruses are controlled, persist or are transmitted to a new host?&amp;quot; It will be answered by studying the natural host species genomes through to the whole organisms and populations by combining fundamental, translational and applied science. This knowledge will then be focused to inform and develop a diverse program of novel disease control strategies. 
An example of our multidisciplinary approach is where we have applied our knowledge of the host immune system, and worked closely with collaborators with expertise in structural biology, bioinformatics and protein expression to understand protective antibody responses. Antibodies represent a major arm of the vertebrate protective immune response and characterising the structures they target provides invaluable information to understand how viruses escape immune recognition and how to confer protection to the host. Surprisingly, only a single cattle antibody structure has been published, in 2013. We have developed high throughput methods based on transcriptomic analysis to identify antigen specific antibody sequences in cattle after immunisation with foot-and-mouth disease virus capsids. Following the development of novel bioinformatics methods, expression of recombinant antibodies and high-resolution cryo-electronmicroscopy, we have demonstrated antibody interactions with the immunising antigen at less than 3&amp;Aring; resolution. This is the first time in any host system, including mice and humans, that antigenic structures have been identified via unbiased global antibody transcriptomic analysis without cell sorting or enrichment. We will apply this pipeline to other cattle viruses and adapt the methods for pigs and poultry.</gtr:exploitationPathways><gtr:id>08344F95-B41C-42BB-8693-DE61A958F268</gtr:id><gtr:outcomeId>56e00426d27349.60070850</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>EADFD38E-3AFF-40CF-AAD2-F86172269335</gtr:id><gtr:title>The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39f0f45ccb631b06876f35646115e28d"><gtr:id>39f0f45ccb631b06876f35646115e28d</gtr:id><gtr:otherNames>Grant CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58c0568d4be0e0.99145853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CABD16F5-0AE7-4FE0-AE75-47326E951855</gtr:id><gtr:title>CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16bd597fd18bbbf01db31734b1fdb5d1"><gtr:id>16bd597fd18bbbf01db31734b1fdb5d1</gtr:id><gtr:otherNames>Carr BV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>58c05690131738.82486728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC2B6E9-F41A-434F-93EC-08585FD004B8</gtr:id><gtr:title>Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39f0f45ccb631b06876f35646115e28d"><gtr:id>39f0f45ccb631b06876f35646115e28d</gtr:id><gtr:otherNames>Grant CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>58c056905769f9.91167654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40D1A1D1-7CD8-4ECD-97D3-58C9B2A31BB1</gtr:id><gtr:title>The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39f0f45ccb631b06876f35646115e28d"><gtr:id>39f0f45ccb631b06876f35646115e28d</gtr:id><gtr:otherNames>Grant CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>58c0568d726ab1.52927592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>871CB0BE-516D-4143-B46B-35ED5FDC78FB</gtr:id><gtr:title>The importance of FMDV localisation in lymphoid tissue.</gtr:title><gtr:parentPublicationTitle>Veterinary immunology and immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39ff5ff45f38098cffe2b99aa48e6ea3"><gtr:id>39ff5ff45f38098cffe2b99aa48e6ea3</gtr:id><gtr:otherNames>Juleff ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0165-2427</gtr:issn><gtr:outcomeId>56cc24ca3f0737.14494576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>519A343B-7B6D-4B81-B7CC-571A0C588AA3</gtr:id><gtr:title>Modelling the within-host dynamics of the foot-and-mouth disease virus in cattle.</gtr:title><gtr:parentPublicationTitle>Epidemics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ddcaa13cc7069515109e7ca9c7b316e"><gtr:id>3ddcaa13cc7069515109e7ca9c7b316e</gtr:id><gtr:otherNames>Howey R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1878-0067</gtr:issn><gtr:outcomeId>544a4d3d9b6073.46046687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92508730-7007-422C-866A-9265E4C219B2</gtr:id><gtr:title>Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in na&amp;Atilde;&amp;macr;ve cattle.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7abe89665635b9626a2d4cd9b966a733"><gtr:id>7abe89665635b9626a2d4cd9b966a733</gtr:id><gtr:otherNames>Juleff N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>544a4d3cd825d4.31286904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AD9C9E8-3985-4639-9D9B-0AED2F2014FF</gtr:id><gtr:title>Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/428c5d3a197922a6f2d37aa48c62f20d"><gtr:id>428c5d3a197922a6f2d37aa48c62f20d</gtr:id><gtr:otherNames>Schley D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58c05690d27667.67076156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC0500C8-FAD7-40CD-8F3B-EA01AE5E77F8</gtr:id><gtr:title>A quantitative assessment of primary and secondary immune responses in cattle using a B cell ELISPOT assay.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261964e5f03badc3c4986a816d0ad0d3"><gtr:id>261964e5f03badc3c4986a816d0ad0d3</gtr:id><gtr:otherNames>Lefevre EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>544a4d3a7e4562.20088473</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001447</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>